The global cancer immunotherapy market was valued at more than US$ 92.11 billion in 2024. It is anticipated to increase at a CAGR of 12.84% between 2024 and 2031. The worldwide cancer immunotherapy ...

HDAC inhibitors and chemotherapy. Ultimately, the aim is to extend the time to relapse and prevent tumour resistance developing, in the hopes of effecting a functional cure for the cancer in more ...

Low Wnt activity during development modifies BBB genes epigenetically for the formation of functional BBB. As a Class-I HDAC inhibitor induces adult CNS ECs to regain Wnt activity and BBB genetic ...

Dec. 12, 2024 — Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, into molecular ...

Australian-led research is unlocking new ways for immunotherapy to better target cancer. Cancer immunotherapy has revolutionized treatment for patients, whereby the body's own immune system is ...

Lost in a daydream? The Cancer moon teams up with Neptune to send your mind on a fantastical adventure. Escape into the visions that bubble up. The ability to see the future may not be so far-fetched.

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

Metastatic cancer to the lungs means that cancer from another region of the body has spread to the lungs. Another term for metastatic cancer to the lungs is secondary cancer in the lungs, as the ...

We have summarized in this article the current state of combination therapy of approved targeted drugs and irradiation. Since the introduction of the first targeted compounds almost (trastuzumab ...

To these reagents we can now add sodiumazide (NaN 3) which also acts as a strong inhibitor of catalase.

After hours: December 13 at 6:24:12 p.m. EST Loading Chart for SHPH ...